Amalgamated Bank Reduces Position in Covetrus, Inc. (NASDAQ:CVET)
Amalgamated Bank Reduces Position in Covetrus, Inc. (NASDAQ:CVET)
Amalgamated Bank decreased its holdings in shares of Covetrus, Inc. (NASDAQ:CVET – Get Rating) by 5.0% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 46,361 shares of the company's stock after selling 2,442 shares during the quarter. Amalgamated Bank's holdings in Covetrus were worth $778,000 as of its most recent SEC filing.
根据合并银行提交给美国证券交易委员会的最新Form 13F文件，该行在第一季度减持了CovetrusInc.(纳斯达克代码：CVET-GET评级)的股票5.0%。该机构投资者在本季度出售了2,442股后，持有该公司46,361股股票。截至最近提交给美国证券交易委员会的文件，合并银行持有的Covetrus股份价值77.8万美元。
Other large investors have also modified their holdings of the company. Point72 Hong Kong Ltd purchased a new stake in shares of Covetrus during the first quarter worth $43,000. Aaron Wealth Advisors LLC purchased a new stake in shares of Covetrus during the first quarter worth $339,000. Crossmark Global Holdings Inc. acquired a new position in shares of Covetrus during the 1st quarter valued at about $170,000. Nisa Investment Advisors LLC boosted its position in shares of Covetrus by 23.4% during the 1st quarter. Nisa Investment Advisors LLC now owns 11,080 shares of the company's stock valued at $186,000 after acquiring an additional 2,100 shares during the last quarter. Finally, American Trust acquired a new position in shares of Covetrus during the 1st quarter valued at about $188,000. Hedge funds and other institutional investors own 92.20% of the company's stock.
其他大型投资者也调整了对该公司的持股。Point72 Hong Kong Ltd在第一季度购买了价值43,000美元的Covetrus新股。Aaron Wealth Advisors LLC在第一季度购买了价值33.9万美元的Covetrus新股。Crossmark Global Holdings Inc.在第一季度收购了Covetrus的新头寸，价值约17万美元。NISA Investment Advisors LLC在第一季度将其在Covetrus股票的头寸增加了23.4%。NISA Investment Advisors LLC现在拥有11,080股该公司股票，价值18.6万美元，该公司在上个季度又收购了2,100股。最后，美国信托在第一季度收购了Covetrus的新头寸，价值约为188,000美元。对冲基金和其他机构投资者持有该公司92.20%的股票。
Analyst Ratings Changes
分析师评级发生变化
Several brokerages have recently weighed in on CVET. TheStreet raised shares of Covetrus from a "d+" rating to a "c-" rating in a research report on Wednesday. Stifel Nicolaus cut shares of Covetrus from a "buy" rating to a "hold" rating and set a $22.00 price target on the stock. in a research report on Monday, June 13th. One analyst has rated the stock with a sell rating and five have assigned a hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of "Hold" and an average target price of $21.40.
几家券商最近也加入了CVeT的行列。华尔街在周三的一份研究报告中将Covetrus的股票评级从“d+”上调至“c-”。Stifel Nicolaus将Covetrus的股票评级从买入下调至持有，并为该股设定了22.00美元的目标价。在6月13日星期一的一份研究报告中。一名分析师对该股的评级为卖出，五名分析师对该公司的评级为持有。根据MarketBeat.com的数据，该公司目前的平均评级为持有，平均目标价为21.40美元。
Insider Buying and Selling
内幕买卖
Covetrus Trading Down 0.1 %
椰子交易下跌0.1%
NASDAQ CVET opened at $20.88 on Friday. The firm's 50-day moving average is $20.83 and its two-hundred day moving average is $19.09. Covetrus, Inc. has a 12 month low of $13.39 and a 12 month high of $21.20. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.88 and a quick ratio of 1.08. The stock has a market capitalization of $2.93 billion, a P/E ratio of -208.80 and a beta of 1.63.
纳斯达克CVET上周五开盘报20.88美元。该公司的50日移动均线切入位为20.83美元，200日移动均线切入位为19.09美元。Covetrus，Inc.的12个月低点为13.39美元，12个月高位为21.20美元。该公司的债务权益比为0.65，流动比率为1.88，速动比率为1.08。该股市值29.3亿美元，市盈率为-208.80，贝塔系数为1.63.
Covetrus (NASDAQ:CVET – Get Rating) last issued its quarterly earnings results on Thursday, August 4th. The company reported $0.20 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.20. The company had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.23 billion. Covetrus had a negative net margin of 0.28% and a positive return on equity of 6.83%. On average, sell-side analysts anticipate that Covetrus, Inc. will post 0.84 earnings per share for the current year.
纳斯达克(股票代码：CVET-GET Rating)最近一次发布季度收益报告是在8月4日(星期四)。该公司公布本季度每股收益(EPS)为0.20美元，超过分析师普遍预期的0.20美元。该公司本季度营收为12.2亿美元，而分析师预期为12.3亿美元。Covetrus的净利润率为负0.28%，股本回报率为正6.83%。卖方分析师平均预计，Covetrus，Inc.本年度每股收益将为0.84美元。
About Covetrus
关于Covetrus
(Get Rating)
(获取评级)
Covetrus, Inc, together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, parasiticides, and vitamins and supplements to wholesale and retail customers.
Covetrus，Inc.及其子公司是一家动物保健技术和服务公司。它从事向批发和零售客户销售动物健康消耗品，包括专利和Covetrus品牌产品、小型设备、实验室产品、大型设备、设备维修服务、品牌和仿制药、疫苗、外科产品、诊断测试、感染控制产品、寄生虫药以及维生素和补充剂。
Featured Stories
专题报道
- Get a free copy of the StockNews.com research report on Covetrus (CVET)
- EV Battery Maker Freyr Set For Major Global Expansion
- MarketBeat: Week in Review 9/26 – 9/30
- This Is A Memorable Time To Buy Into Micron Technology
- Declining Profits Challenge the CarMax Value Proposition
- Thor Industries Hammers Out A Bottom
- 免费获取StockNews.com关于Covetrus的研究报告(CVeT)
- 电动汽车电池制造商Freyr将在全球大举扩张
- MarketBeat：回顾一周9/26-9/30
- 这是买入美光科技的难忘时刻
- 利润下降对CarMax价值主张的挑战
- 雷神工业走出谷底
Want to see what other hedge funds are holding CVET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Covetrus, Inc. (NASDAQ:CVET – Get Rating).
想看看还有哪些对冲基金持有CVeT吗？访问HoldingsChannel.com获取Covetrus，Inc.(纳斯达克代码：CVeT-GET Rating)的最新13F备案文件和内幕交易信息。
Receive News & Ratings for Covetrus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Covetrus and related companies with MarketBeat.com's FREE daily email newsletter.
接受《椰子日报》的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Covetrus和相关公司的最新新闻和分析师评级的每日简要摘要。